Singapore-based TauRx will update on Phase III studies of its tau aggregation inhibitor LMTX in a podium presentation at the Alzheimer’s Association…

An HIV vaccine research team led by Texas Biomedical Research Institute has secured $23 million in NIH grant funding to explore an approach that will utilize…

What’s a quick way to nab market share from a competitor? Roll out a superior product at the same price--and that’s what Shire’s confident it’s doing with dry…

Boehringer was hoping to get some more mileage out of targeted lung cancer med Gilotrif. But those hopes have been dashed by a data monitoring committee.

Pharma's gifts to politicians--one, in particular--have been in the spotlight since presidential candidate Hillary Clinton announced her VP pick Friday.

Roche won another reprieve in its fight againstthousands of Accutane safety claims. The drugmaker persuaded a New Jersey appeals court to overturn an $18M jury…

With the vast majority of drugs and drug ingredients being manufactured outside the U.S., the FDA has had to step up its international oversight and often ban…

Bristol-Myers Squibb’s immunotherapy Opdivo has been powering ahead, racking up sales and new FDA approvals one after another. And with cancer-fighting…

Shortages of vaccines at clinics in China have predictably followed a move to eliminate middlemen from the sales chain.